Pembrolizumab with etoposide and a platinum-based compound for untreated extensive-stage small-cell lung cancer [ID1509]

  • Discontinued
  • GID-TA10413
Consultation on the draft scope and provisional matrix of consultees and commentators, with comments requested by 10 January 2020.